Eli Lilly and Company (LLY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/14/26
Lilly says Foundayo has captured over 30% of new US patients on oral weight-loss drugsReuters • 09/14/26
Eli Lilly Eyes Obesity Access Expansion With Zepbound, Foundayo and Pipeline BetsMarketBeat • 09/14/26
Eli Lilly Fell Like a Rock Over the Last Month: This Big Bank Expects 45% Returns Over The Next Twelve24/7 Wall Street • 09/14/26
People are taking bootleg versions of an Eli Lilly drug that isn't approved yet. Ohio wants it to stop.WSJ • 09/14/26
Novartis Just Shook Up a Multibillion-Dollar Drug Race. What It Means for Eli Lilly Stock.The Motley Fool • 09/14/26
Eli Lilly's Immunology Push Builds New Growth Engines Beyond GLP-1sZacks Investment Research • 09/11/26
Lilly completes acquisition of AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditionsPRNewsWire • 09/11/26
Eli Lilly Stock Has Become a Trillion-Dollar Giant. Is It Too Late to Buy?24/7 Wall Street • 09/10/26
Prediction: This Is What a $5,000 Investment in Eli Lilly Will Be Worth in 2031The Motley Fool • 09/09/26
Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%24/7 Wall Street • 09/08/26
Wall Street Bulls Look Optimistic About Lilly (LLY): Should You Buy?Zacks Investment Research • 09/08/26
Eli Lilly Has Been on an Acquisition Spree. How Much Could Its Latest Deals Boost the Stock?The Motley Fool • 09/07/26
Here's Why Billionaires Stanley Druckenmiller and Ken Griffin Are Loading Up on Eli Lilly StockThe Motley Fool • 09/06/26
Prediction: Here's What a $5,000 Investment in Eli Lilly Could Look Like in 5 YearsThe Motley Fool • 09/05/26